Characteristics of chronic GVHD after cord blood transplantation

Area of Science:

• Hematology
• Transplantation Immunology
• Oncology

Background:

• Chronic graft-versus-host disease (GVHD) diagnosis post-cord blood transplantation (CBT) traditionally relied on specific criteria.
• Recent advancements introduced National Institutes of Health (NIH) criteria for a more nuanced evaluation.

Purpose of the Study:

• To prospectively evaluate chronic GVHD in CBT recipients using both traditional and NIH criteria.
• To characterize the clinical presentation of chronic GVHD post-CBT.

Main Methods:

• A cohort of 87 adult and pediatric patients receiving unrelated CBT for hematologic malignancies was studied.
• Patients were assessed prospectively using both traditional and NIH chronic GVHD diagnostic criteria.

Main Results:

• A 2-year probability of 64% for traditionally defined chronic GVHD was observed.
• Among these, 46% met NIH criteria for persistent, recurrent, or late acute GVHD; 44% had overlap chronic GVHD; only 13% had classic chronic GVHD.
• Patients discontinuing immunosuppression achieved median corticosteroid cessation at 315 days and all SI at 353 days.

Conclusions:

• Chronic GVHD following CBT, when diagnosed by traditional criteria, frequently exhibits clinical features more characteristic of acute GVHD.
• The NIH criteria provide a more accurate classification, identifying a higher proportion of persistent, recurrent, or overlap forms over classic chronic GVHD.